JPRN-jRCT2080222141未知1 期
A multiple dose study of HP-3060 in patients with allergic rhinitis.
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Subjects with a disease duration of 2 years or more and a positive result for serum specific IgE antibody on quantitative assessment.
排除标准
- •- Allergic rhinitis complicated by other types of rhinitis, such as infectious rhinitis, vasomotor rhinitis, or eosinophilic rhinitis
- •- Allergic rhinitis complicated by chronic sinusitis
- •- Hyposensitization therapy or nonspecific immunotherapy
研究者
相似试验
未知
3 期
ong-term study of HP-3060Perennial allergic rhinitisJPRN-jRCT2080222924Hisamitsu Pharmaceutical Co., Inc.
已完成
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223788Hisamitsu Pharmaceutical Co., Inc.24
未知
2 期
Single dose pharmacokinetic study of HP-3060Allergic rhinitisJPRN-jRCT2080223009Hisamitsu Pharmaceutical Co., Inc.
已完成
1 期
A single-dose study of HP-6050Healthy adultJPRN-jRCT2031220092Inakura Hiroshi16
未知
2 期
Phase II clinical study in patients with Parkinson's disease.Parkinson's diseaseJPRN-jRCT2080221631Hisamitsu Pharmaceutical Co., Inc.